{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:09Z","timestamp":1786120269679,"version":"build-2736575974"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ajp.0b013e318243075c","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T01:24:22Z","timestamp":1325294662000},"page":"726-743","source":"Crossref","is-referenced-by-count":40,"title":["Painful Diabetic Polyneuropathy"],"prefix":"10.1097","volume":"28","author":[{"given":"Vincenza","family":"Spallone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lacerenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Sicuteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marchettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210204","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes.","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"R2-13-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(96)00851-7","article-title":"Pain from excitation of identified muscle nociceptors in humans.","volume":"740","author":"Marchettini","year":"1996","journal-title":"Brain Res"},{"key":"R3-13-20210204","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia.","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"R4-13-20210204","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pain.2008.04.025","article-title":"The Kyoto protocol of IASP Basic Pain Terminology.","volume":"137","author":"Loeser","year":"2008","journal-title":"Pain"},{"key":"R5-13-20210204","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pain.2006.10.034","article-title":"Using screening tools to identify neuropathic pain.","volume":"127","author":"Bennett","year":"2007","journal-title":"Pain"},{"key":"R6-13-20210204","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the Neuropathic Pain Symptom Inventory.","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"R7-13-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpain.2004.11.007","article-title":"The S-LANSS Score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.","volume":"6","author":"Bennett","year":"2005","journal-title":"J Pain"},{"key":"R8-13-20210204","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00002508-200309000-00004","article-title":"Development of a neuropathic pain questionnaire.","volume":"19","author":"Krause","year":"2003","journal-title":"Clin J Pain"},{"key":"R9-13-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"R11-13-20210204","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079906X115702","article-title":"Development and testing of a neuropathic pain screening questionnaire: ID pain.","volume":"22","author":"Portenoy","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R12-13-20210204","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the Neuropathic Pain Symptom Inventory.","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"R13-13-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","article-title":"Development and initial validation of an expanded and revised version of the Short-Form McGill Pain Questionnaire (SF-MPQ-2).","volume":"144","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"R14-13-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3959(83)90143-4","article-title":"Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.","volume":"17","author":"Daut","year":"1983","journal-title":"Pain"},{"key":"R15-13-20210204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"R16-13-20210204","doi-asserted-by":"crossref","first-page":"e10000045","DOI":"10.1371\/journal.pmed.1000045","article-title":"Tools for assessing neuropathic pain.","volume":"6","author":"Cruccu","year":"2009","journal-title":"PLoS Med"},{"key":"R18-13-20210204","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jpain.2008.02.008","article-title":"Neuroimaging of pain: advances and future prospects.","volume":"9","author":"Stephenson","year":"2008","journal-title":"J Pain"},{"key":"R19-13-20210204","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1468-1331.2010.02969.x","article-title":"EFNS guidelines on neuropathic pain assessment: revised 2009.","volume":"17","author":"Cruccu","year":"2010","journal-title":"Eur J Neurol"},{"key":"R20-13-20210204","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"A quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and references values.","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"key":"R21-13-20210204","doi-asserted-by":"crossref","first-page":"e1000047","DOI":"10.1371\/journal.pmed.1000047","article-title":"A novel tool for the assessment of pain: validation in low back pain.","volume":"6","author":"Scholz","year":"2009","journal-title":"PLoS Med"},{"key":"R22-13-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1533-2500.2007.00164.x","article-title":"A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia and less commonly studied neuropathic pain conditions.","volume":"8","author":"Sadosky","year":"2008","journal-title":"Pain Pract"},{"key":"R23-13-20210204","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"R24-13-20210204","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1002\/dmrr.817","article-title":"Painful diabetic neuropathy: treatment and future aspects.","volume":"24","author":"Ziegler","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"R25-13-20210204","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic somatic neuropathies.","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"R26-13-20210204","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy.","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"R27-13-20210204","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","article-title":"Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.","volume":"35","author":"Van Acker","year":"2009","journal-title":"Diabetes Metab"},{"key":"R28-13-20210204","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc05-2228","article-title":"The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes.","volume":"29","author":"Davies","year":"2006","journal-title":"Diabetes Care"},{"key":"R29-13-20210204","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy. The MONICAKORA Augsburg Surveys S2 and S3.","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"R30-13-20210204","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-5491.2004.01271.x","article-title":"Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes.","volume":"21","author":"Daousi","year":"2004","journal-title":"Diabet Med"},{"key":"R31-13-20210204","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective.","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"R32-13-20210204","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy.","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"R33-13-20210204","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/dc08-1241","article-title":"Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.","volume":"32","author":"Panero","year":"2009","journal-title":"Diabetes Care"},{"key":"R34-13-20210204","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejpain.2010.06.011","article-title":"Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function.","volume":"15","author":"Spallone","year":"2011","journal-title":"Eur J Pain"},{"key":"R35-13-20210204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/diab.23.5.418","article-title":"Diabetic neuropathic cachexia.","volume":"23","author":"Ellenberg","year":"1974","journal-title":"Diabetes"},{"key":"R36-13-20210204","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp.46.6.491","article-title":"The natural history of acute painful neuropathy in diabetes mellitus.","volume":"46","author":"Archer","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R37-13-20210204","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/brain\/awg029","article-title":"Inflammatory vasculopathy in multifocal diabetic neuropathy.","volume":"126","author":"Said","year":"2003","journal-title":"Brain"},{"key":"R38-13-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00685978","article-title":"Acute painful diabetic neuropathy precipitated by strict glycaemic control.","volume":"72","author":"Llewelyn","year":"1986","journal-title":"Acta Neuropathol"},{"key":"R39-13-20210204","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bmj.2.4951.1287","article-title":"Diabetic amyotrophy.","volume":"2","author":"Garland","year":"1955","journal-title":"Br Med J"},{"key":"R40-13-20210204","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/WNL.53.9.2113","article-title":"Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.","volume":"53","author":"Dyck","year":"1999","journal-title":"Neurology"},{"key":"R41-13-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage.","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"R42-13-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain - a clinical perspective.","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R43-13-20210204","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1526-4637.2007.00349.x","article-title":"Diabetic peripheral neuropathic pain: recognition and management.","volume":"8","author":"Cole","year":"2007","journal-title":"Pain Med"},{"key":"R44-13-20210204","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","article-title":"Painful diabetic neuropathy: epidemiology, natural history, early diagnosis and treatment options.","volume":"9","author":"Veves","year":"2008","journal-title":"Pain Med"},{"key":"R45-13-20210204","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2005.07.039","article-title":"Functional alteration of inhibitory influences on spinal motor output in painful diabetic neuropathy in rats.","volume":"389","author":"Tanabe","year":"2005","journal-title":"Neurosci Lett"},{"key":"R46-13-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrneurol.2010.90","article-title":"Neuropathic pain in diabetesevidence for a central mechanism.","volume":"6","author":"Fischer","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"R47-13-20210204","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.2009.01235.x","article-title":"Cortical disinhibition in diabetic patients with neuropathic pain.","volume":"120","author":"Turgut","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"R48-13-20210204","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbadis.2008.11.005","article-title":"Diabetes and the peripheral nerve.","volume":"1792","author":"Obrosova","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"R49-13-20210204","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WCO.0b013e32830b84cb","article-title":"Diabetic polyneuropathy: an update.","volume":"21","author":"Zochodne","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"R50-13-20210204","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7547\/0970394","article-title":"Painful diabetic peripheral neuropathy.","volume":"97","author":"Smith","year":"2007","journal-title":"J Am Podiatr Med Assoc"},{"key":"R51-13-20210204","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/diacare.29.04.06.dc05-2180","article-title":"The relationship among pain, sensory loss and small nerve fibers in diabetes.","volume":"29","author":"Sorensen","year":"2006","journal-title":"Diabetes Care"},{"key":"R52-13-20210204","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/db07-0285","article-title":"Surrogate markers of small fiber damage in human diabetic neuropathy.","volume":"56","author":"Quattrini","year":"2007","journal-title":"Diabetes"},{"key":"R53-13-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: quality of life impact, costs and cost effectiveness of therapy.","volume":"27","author":"OConnor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"R54-13-20210204","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications.","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"R55-13-20210204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/diacare.28.1.65","article-title":"The effect of chronic pain on diabetes patients self-management.","volume":"28","author":"Krein","year":"2005","journal-title":"Diabetes Care"},{"key":"R56-13-20210204","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/01.ajp.0000210910.49923.09","article-title":"Sleep impairment in patients with painful diabetic peripheral neuropathy.","volume":"22","author":"Zelman","year":"2006","journal-title":"Clin J Pain"},{"key":"R57-13-20210204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00592-008-0030-2","article-title":"Italian standards for diabetes mellitus 2007: executive summary: Diabete Italia, AMD Associazione Medici Diabetologi, SID Societa Italiana di Diabetologia.","volume":"45","author":"De Micheli","year":"2008","journal-title":"Acta Diabetol"},{"key":"R59-13-20210204","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"R60-13-20210204","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/diacare.20.5.836","article-title":"A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic neuropathy Committee.","volume":"20","author":"Fedele","year":"1997","journal-title":"Diabetes Care"},{"key":"R61-13-20210204","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"issue":"suppl 10","key":"R62-13-20210204","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.amjmed.2009.04.006","article-title":"Assessment of neuropathic pain in primary care.","volume":"122","author":"Haanpaa","year":"2009","journal-title":"Am J Med"},{"key":"R63-13-20210204","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L","article-title":"Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.","volume":"15","author":"Boulton","year":"1998","journal-title":"Diabet Med"},{"key":"R64-13-20210204","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association.","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"R65-13-20210204","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/01.WNL.0000058546.16985.11","article-title":"Quantitative sensory testing: report on the Therapeutic and Technology Assessment Subcommittee of the American Academy of Neurology.","volume":"60","author":"Shy","year":"2003","journal-title":"Neurology"},{"key":"R66-13-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic.","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"key":"R67-13-20210204","first-page":"1","article-title":"Painful diabetic neuropathy: diagnostic and therapeutical approach to an emerging problem.","volume":"9","author":"Spallone","year":"2009","journal-title":"MeDia"},{"key":"R68-13-20210204","first-page":"10","article-title":"Painful diabetic neuropathis. Case reports and diagnostic criteria.","volume":"13","author":"Lacerenza","year":"2006","journal-title":"Pathos"},{"key":"R69-13-20210204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pmrj.2008.11.010","article-title":"Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.","volume":"1","author":"England","year":"2009","journal-title":"PM R"},{"key":"R70-13-20210204","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"R71-13-20210204","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mus.20846","article-title":"Does impaired glucose metabolism cause polyneuropathy Review of previous studies and design of a prospective controlled population-based study.","volume":"36","author":"Dyck","year":"2007","journal-title":"Muscle Nerve"},{"key":"R72-13-20210204","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy.","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"R73-13-20210204","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpain.2008.07.007","article-title":"Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.","volume":"13","author":"Ziegler","year":"2009","journal-title":"Eur J Pain"},{"key":"R74-13-20210204","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","article-title":"Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICAKORA Augsburg Surveys S2 and S3.","volume":"10","author":"Ziegler","year":"2009","journal-title":"Pain Med"},{"key":"R75-13-20210204","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.","volume":"21","author":"Ziegler","year":"2004","journal-title":"Diabet Med"},{"key":"R76-13-20210204","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alfa-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"key":"R78-13-20210204","first-page":"S63","article-title":"Antioxidant treatment with alpha-lipoic acid in diabetic polyneuropathy: a 4-year randomized double-blind trial (NATHAN 1).","volume":"50","author":"Ziegler","year":"2007","journal-title":"Diabetologia"},{"key":"R79-13-20210204","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.2337\/dc07-1374","article-title":"Whither clinical research in diabetic sensorimotor peripheral neuropathy Problems of end point selection for clinical trials.","volume":"30","author":"Boulton","year":"2007","journal-title":"Diabetes Care"},{"key":"R80-13-20210204","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/dmrr.1225","article-title":"Painful diabetic peripheral neuropathy: Consensus Recommendations on Diagnosis, Assessment and management.","volume":"27","author":"Tesfaye","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"R81-13-20210204","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy.","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"R82-13-20210204","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jpain.2006.04.013","article-title":"Burden of illness in painful diabetic peripheral neuropathy: the patients perspectives.","volume":"7","author":"Gore","year":"2006","journal-title":"J Pain"},{"key":"R83-13-20210204","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0025-6196(11)61474-2","article-title":"Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.","volume":"81","author":"Argoff","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R84-13-20210204","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms and treatment.","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"R85-13-20210204","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R86-13-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.39213.565972.AE","article-title":"Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.","volume":"335","author":"Wong","year":"2007","journal-title":"BMJ"},{"key":"R87-13-20210204","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1464-5491.2007.02093.x","article-title":"Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy.","volume":"24","author":"Jose","year":"2007","journal-title":"Diabet Med"},{"key":"R89-13-20210204","first-page":"S269","article-title":"New and emerging treatment options for neuropathic pain.","volume":"12","author":"Gidal","year":"2006","journal-title":"Am J Manag Care"},{"key":"R90-13-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"R91-13-20210204","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"key":"R92-13-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy.","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"R93-13-20210204","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"key":"R94-13-20210204","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1526-4637.2007.00305.x","article-title":"Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.","volume":"8","author":"Pritchett","year":"2007","journal-title":"Pain Med"},{"key":"R95-13-20210204","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.2010.484418","article-title":"Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.","volume":"9","author":"Hall","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R97-13-20210204","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1526-4637.2007.00351.x","article-title":"Safety profile of treatment in diabetic peripheral neuropathic pain.","volume":"8","author":"Robinson-Papp","year":"2007","journal-title":"Pain Med"},{"key":"R98-13-20210204","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2337\/dc06-2009","article-title":"Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.","volume":"30","author":"Ziegler","year":"2007","journal-title":"Diabetes Care"},{"key":"R99-13-20210204","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jdiacomp.2008.07.004","article-title":"Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.","volume":"23","author":"Wernicke","year":"2009","journal-title":"J Diabetes Complications"},{"key":"R100-13-20210204","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/157488609787354404","article-title":"Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.","volume":"4","author":"Wasan","year":"2009","journal-title":"Curr Drug Saf"},{"key":"R101-13-20210204","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1533-2500.2009.00294.x","article-title":"Does pain cause the perception of fatigue in patients with chronic pain Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.","volume":"9","author":"Fishbain","year":"2009","journal-title":"Pain Pract"},{"key":"R102-13-20210204","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/dmrr.1000","article-title":"Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.","volume":"25","author":"Skljarevski","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"R103-13-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/qjmed\/hch007","article-title":"Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.","volume":"97","author":"Kochar","year":"2004","journal-title":"QJM"},{"key":"R104-13-20210204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/01.ajp.0000210957.39621.b2","article-title":"Lacosamide in painful diabetic peripheral neuropathy. a phase 2 double-blind placebo-controlled study.","volume":"23","author":"Rauck","year":"2007","journal-title":"Clin J Pain"},{"key":"R105-13-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"key":"R106-13-20210204","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.","volume":"9","author":"Dogra","year":"2005","journal-title":"Eur J Pain"},{"key":"R107-13-20210204","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"R108-13-20210204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2004.00338.x","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.","volume":"110","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"R109-13-20210204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects.","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"key":"R110-13-20210204","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jpain.2009.01.322","article-title":"Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.","volume":"10","author":"Shaibani","year":"2009","journal-title":"J Pain"},{"key":"R111-13-20210204","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/AJP.0b013e318196d2b6","article-title":"Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.","volume":"25","author":"Wymer","year":"2009","journal-title":"Clin J Pain"},{"key":"R112-13-20210204","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/dc09-1578","article-title":"Efficacy and safety of lacosamide in painful diabetic neuropathy.","volume":"33","author":"Ziegler","year":"2010","journal-title":"Diabetes Care"},{"key":"R113-13-20210204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pain.2008.11.019","article-title":"Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta Cavalpha2-delta ligands.","volume":"142","author":"Taylor","year":"2009","journal-title":"Pain"},{"key":"R114-13-20210204","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2337\/dc08-1450","article-title":"Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.","volume":"32","author":"Sandercock","year":"2009","journal-title":"Diabetes Care"},{"key":"R116-13-20210204","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"R117-13-20210204","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"R118-13-20210204","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"R120-13-20210204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.","volume":"12","author":"Tolle","year":"2008","journal-title":"Eur J Pain"},{"key":"R121-13-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600 mgd for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"key":"R122-13-20210204","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"R123-13-20210204","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1464-5491.2009.02806.x","article-title":"Amitriptyline vs pregabalin in painful diabetic neuropathy: a randomized, double-blind clinical trial.","volume":"26","author":"Bansal","year":"2009","journal-title":"Diabet Med"},{"key":"R125-13-20210204","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurol"},{"key":"R126-13-20210204","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jpain.2010.02.008","article-title":"Approaches to improve pain relief while minimizing opioid abuse liability.","volume":"11","author":"Webster","year":"2010","journal-title":"J Pain"},{"key":"R127-13-20210204","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1358\/dot.2008.44.11.1308916","article-title":"Tramadol: basic pharmacology and emerging concepts.","volume":"11","author":"Reeves","year":"2008","journal-title":"Drugs Today"},{"key":"R128-13-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.ajp.0000210945.27052.b3","article-title":"The coexistence of neuropathic pain, sleep and psychiatric disorders: a novel treatment approach.","volume":"23","author":"Argoff","year":"2007","journal-title":"Clin J Pain"},{"key":"R129-13-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/AJP.0b013e31802b582f","article-title":"Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.","volume":"23","author":"Portenoy","year":"2007","journal-title":"Clin J Pain"},{"key":"R130-13-20210204","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1185\/03007990903047880","article-title":"5 lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.","volume":"25","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R131-13-20210204","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1185\/03007990903048078","article-title":"Efficacy and safety of combination therapy with 5 lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.","volume":"25","author":"Baron","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R132-13-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal.","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"R133-13-20210204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2006.12.003","article-title":"Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double-blind placebo-controlled cross-over study.","volume":"77","author":"Agrawal","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"R134-13-20210204","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"R135-13-20210204","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"R136-13-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2340\/16501977-0554","article-title":"Electrotherapy for the treatment of painful diabetic peripheral neuropathy: a review.","volume":"42","author":"Pieber","year":"2010","journal-title":"J Rehabil Med"},{"key":"R137-13-20210204","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1464-5491.2004.01410.x","article-title":"Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy.","volume":"22","author":"Daousi","year":"2005","journal-title":"Diabet Med"},{"key":"R138-13-20210204","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00125-005-1734-2","article-title":"Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.","volume":"48","author":"Bosi","year":"2005","journal-title":"Diabetologia"},{"key":"R139-13-20210204","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpainsymman.2009.05.021","article-title":"A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation and quality of life in patients with diabetic peripheral neuropathy.","volume":"39","author":"Swislocki","year":"2010","journal-title":"J Pain Symptom Manag"},{"key":"R140-13-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1212\/WNL.0b013e3181c918fc","article-title":"Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.","volume":"74","author":"Dubinsky","year":"2010","journal-title":"Neurology"},{"key":"R141-13-20210204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R143-13-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S2.1","article-title":"American Association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan.","volume":"17","author":"Handelsman","year":"2011","journal-title":"End Pract"},{"key":"R144-13-20210204","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1210\/jc.2010-0892","article-title":"The approach to the management of the patient with neuropathic pain.","volume":"95","author":"Vinik","year":"2010","journal-title":"Pain J Clin Endocinol Metab"},{"key":"R145-13-20210204","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin or their combination for neuropathic pain.","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"R146-13-20210204","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial.","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"R147-13-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejpain.2007.12.010","article-title":"Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.","volume":"12","author":"Hanna","year":"2008","journal-title":"Eur J Pain"},{"key":"R148-13-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpain.2009.09.003","article-title":"A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.","volume":"11","author":"Zin","year":"2010","journal-title":"J Pain"},{"key":"R149-13-20210204","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/dmrr.360","article-title":"Understanding the impact of painful diabetic neuropathy.","volume":"19","author":"Quattrini","year":"2003","journal-title":"Diabetes Metab Res Rev"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AJP.0b013e318243075c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:46Z","timestamp":1786047886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002508-201210000-00013"}},"subtitle":["Approach to Diagnosis and Management"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":139,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e318243075c","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}